A phase 1 trial disaster: the implications for research.
Torjesen
Ingrid
I
D000911:Antibodies, Monoclonal / Q000633:toxicity; D017321:Clinical Trials, Phase I as Topic / Q000009:adverse effects* / Q000592:standards*; D006801:Humans; D012106:Research / Q000592:standards*
D000911:Antibodies, Monoclonal